October 19, 2017 - 09:00 h

Inaugural Event and Scientific Symposium of the Austrian Platform for Personalized Medicine

Van Swieten Hall of the Medical University of Vienna, Van-Swieten-Gasse 1a, 1090 Vienna

Personalized medicine is one of the grand societal challenges of the present and future. The Austrian Platform for Personalized Medicine has been initiated by the Federal Ministry of Science, Research and Economy (BMWFW). It establishes a national networking platform that seeks to connect all stakeholders and interested parties in the field. The platform is open to all individuals and organizations that would like to contribute to the future of personalized medicine in Austria and beyond.

Participants are invited to submit abstracts with suggested contributions via the registration web page. Of particular interest will be poster presentations and booths by which relevant stakeholders will present themselves.

October 23, 2017 - 14:00 h

CeMMinar Michael Wagner

CeMM Level 8, Seminar Room 

Michael Wagner

Department of Microbiology and Ecosystem Science, University of Vienna, Austria

"Functional microbiome analysis with single cell resolution"

Host: Giulio Superti-Furga

October 25, 2017 - 14:00 h

Impromptu Greg Sienski

Related Files

Share

Anna Spiegel Research Building, Seminar Room 3

Greg Sienski

Laboratory of David M. Sabatini, Whitehead Institute/MIT

"Metabolic consequences of genetic variation”

Host: Giulio Superti-Furga

Biosketch

Greg Sienski studied biotechnology at Jagiellonian University in Cracow. He obtained his PhD in 2014 in the laboratory of Julius Brennecke at IMBA (Vienna).  In 2015 he started his postdoctoral training with Susan Lindquist and later David Sabatini at Whitehead Institute (Cambridge, MA, USA). His research focuses on deciphering molecular perturbations caused by genetic mutations that have been linked to prevalent human diseases. In particular, he is interested in plasticity of lipid metabolism. 

November 14, 2017 - 14:00 h

Impromptu Thomas Baumert

Related Files

Share

CeMM Level 8, Seminar Room 

Thomas Baumert

Institute of Viral and Liver Disease, University of Strasbourg, France

"Virus-host interactions and hepatocellular carcinoma"

Host: Andreas Bergthaler

Biosketch:

Thomas F. Baumert, MD is Professor of Medicine, head of the Inserm-University of Strasbourg Research Institute of Viral and Liver Disease (Inserm UMR_S1110) and director of the Laboratory of Excellence HepSYS at the University of Strasbourg. He has received several awards including the Chair of Excellence and Laboratory of Excellence Awards of the French National Research Agency, and the Prix Galien France and Prix Galien International, for the discovery of hosttargeting entry inhibitors for HCV infection. Most recently he received a European Research Council Advanced Grant for the discovery and development of novel approaches to prevent and treat chronic liver disease. He has published more than 250 scientific articles and is an inventor on 15 patents and patent applications. In his translational work he focuses on novel approaches for HBV cure, development of an HCV vaccine and prevention of liver cancer.

November 17, 2017 - 14:30 h

Impromptu Gonçalo Bernardes

CeMM Level 8, Seminar Room 

Gonçalo Bernardes

Department of Chemistry, University of Cambridge, United Kingdom

"Chemical physiology of protein conjugates and natural products

Host: Giulio Superti-Furga

Biosketch

Dr. Gonçalo Bernardes is a Group Leader at the Department of Chemistry, University of Cambridge, U.K.. He is also the Director of the Chemical Biology and Pharmaceutical Biotechnology Unit at the Instituto de Medicina Molecular, Portugal. After completing his D.Phil. degree in 2008 at the University of Oxford, U.K., he undertook postdoctoral work at the Max-Planck Institute of Colloids and Interfaces, Germany, and the ETH Zürich, Switzerland, and worked as a Group Leader at Alfama Lda in Portugal. He started his independent research career in 2013, and his research group interests focus on the development of site-selective chemical protein modification for basic biology and drug development. He is a Royal Society University Research Fellow and the awardee of a Starting Grant from the European Research Council (TagIt). He has received a number of accolades including the Royal Society of Chemistry Harrison-Meldola prize and the ChemSocRev Emerging Investigator Lectureship, both in 2016. Just recently he co-founded and spun-out two companies, Proterris Oncology and AI.Tex that explore CO’s immune roles in cancer and the use of artificial intelligence method to unravel the targets of small molecules, respectively. 

December 04, 2017 - 14:00 h

CeMMinar Raul Andino

Related Files

Share

CeMM Level 8, Seminar Room

Raul Andino

Department of Microbiology and Immunology, University of California, United States

"RNA virus evolution: mechanisms and consequences during infection"

Host: Andreas Bergthaler

Biosketch

Raul Andino, Ph.D., is professor of microbiology and immunology at the University of California, San Francisco, where he specializes in RNA viruses, with a focus on molecular biology, immunology, and evolutionary biology. He received his Masters and Ph.D. degrees from the University of Buenos Aires. His research interests focus on RNA virus replication, pathogenesis and evolution. His work examines at a molecular level the mechanisms of viral replication, such as protein synthesis, genome replication, and viral particle formation and their interplay with cellular processes. He studies the host strategies that control virus infection, including innate immune responses, such as RNAi and the mechanisms that the virus has evolved to suppress the host antiviral responses. Lastly, in a unique combination between experimental and computational techniques, he is developing novel and exciting approaches to study virus population dynamics and evolution at the molecular and genomic level.